All In Biotech

Drug Trial Radar · NCT06843044

Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders

An Open-label, Comparative, Randomized, Multicenter Phase IV Clinical Study to Evaluate the Clinical Efficacy and Safety of the Drug Ranquilon, Tablets, 1 mg, in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders

Last checked: Nov 20, 2026Latest source record: Jul 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Jan 13, 2025

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Valenta Pharm JSCIndustry
Sponsor type
Industry
First posted
Feb 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study is to evaluate the efficacy and safety of the drug Ranquilon, 1 mg tablets, at a dosage of 6 mg/day compared to the drug Afobazole, 10 mg tablets, at a dosage of 30 mg/day for the treatment of patients with anxiety disorders due to neurasthenia and adjustment disorders.

Conditions

  • Anxiety
  • Neurasthenia
  • Adjustment Disorders

Interventions

  • RanquilonDrug

    1 mg tablets

  • AfobazoleDrug

    10 mg tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of patients with a significant reduction in anxiety levels (by 50% or more) on Hamilton Anxiety Rating Scale (HARS) compared to baseline on Day 29 ± 1 (Visit 3)Time frame: Day 29 ± 1 (Visit 3)

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Engels Psychiatric Hospital State Health Care Institution of the Ministry of Health of the Saratov Region

    Engel's, Russia · Recruiting

  • Unimed-C Jsc

    Moscow, Russia · Recruiting

  • Aurora MedFort LLC

    Saint Petersburg, Russia · Recruiting

  • Limited Liability Company "Research Center Eco-Safety"

    Saint Petersburg, Russia · Recruiting

  • Limited Liability Company "Stepmed Clinic"

    Saint Petersburg, Russia · Recruiting

  • Saratov City Psychoneurological Dispensary

    Saratov, Russia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.